Xu B - Search Results

1

Percutaneous Intramyocardial Septal Radiofrequency Ablation for Hypertrophic Obstructive Cardiomyopathy.

Liu L, Li J, Zuo L, Zhang J, Zhou M, Xu B, Hahn RT, Leon MB, Hsi DH, Ge J, Zhou X, Zhang J, Ge S, Xiong L. Liu L, et al. Among authors: xu b. J Am Coll Cardiol. 2018 Oct 16;72(16):1898-1909. doi: 10.1016/j.jacc.2018.07.080. J Am Coll Cardiol. 2018. PMID: 30309466 Free article.

2

Efficacy and safety of Firebird sirolimus-eluting stent in treatment of complex coronary lesions in Chinese patients: one-year clinical and eight-month angiographic outcomes from the FIREMAN registry.

Li Y, Li CX, Wang HC, Xu B, Fang WY, Ge JB, Wang WM, Qiao SB, Chen JP, Shen WK, Jiang H, Cong HL, Pu XQ, Qin YW, Jin HG, Cao Y, Huang H. Li Y, et al. Among authors: xu b. Chin Med J (Engl). 2011 Mar;124(6):817-24. Chin Med J (Engl). 2011. PMID: 21518586

3

First report of a novel abluminal groove filled biodegradable polymer rapamycin-eluting stent in de novo coronary artery disease: results of the first in man FIREHAWK trial.

Qian J, Xu B, Lansky AJ, Yang YJ, Qiao SB, Wu YJ, Chen J, Hu FH, Yang WX, Mintz GS, Leon MB, Gao RL. Qian J, et al. Among authors: xu b. Chin Med J (Engl). 2012 Mar;125(6):970-6. Chin Med J (Engl). 2012. PMID: 22613516 Clinical Trial.

4

Comparison of double kissing crush versus Culotte stenting for unprotected distal left main bifurcation lesions: results from a multicenter, randomized, prospective DKCRUSH-III study.

Chen SL, Xu B, Han YL, Sheiban I, Zhang JJ, Ye F, Kwan TW, Paiboon C, Zhou YJ, Lv SZ, Dangas GD, Xu YW, Wen SY, Hong L, Zhang RY, Wang HC, Jiang TM, Wang Y, Chen F, Yuan ZY, Li WM, Leon MB. Chen SL, et al. Among authors: xu yw, xu b. J Am Coll Cardiol. 2013 Apr 9;61(14):1482-8. doi: 10.1016/j.jacc.2013.01.023. Epub 2013 Mar 10. J Am Coll Cardiol. 2013. PMID: 23490040 Free article. Clinical Trial.

5

Cooperation, innovation and transition: the new focus of the China Interventional Therapeutics (CIT) congress.

Gao RL, Xu B, Leon MB. Gao RL, et al. Among authors: xu b. Chin Med J (Engl). 2013 Mar;126(6):1003-4. Chin Med J (Engl). 2013. PMID: 23506568 No abstract available.

6

Efficacy and safety of FIREHAWK® abluminal groove filled biodegradable polymer sirolimus-eluting stents for the treatment of long coronary lesions: nine-month angiographic and one-year clinical results from TARGET I trial long cohort.

Xu B, Gao RL, Zhang RY, Wang HC, Li ZQ, Yang YJ, Ma CS, Han YL, Lansky AJ, Huo Y, Li W, Leon MB. Xu B, et al. Chin Med J (Engl). 2013 Mar;126(6):1026-32. Chin Med J (Engl). 2013. PMID: 23506573

7

A randomised comparison of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: clinical and angiographic follow-up of the TARGET I trial.

Gao RL, Xu B, Lansky AJ, Yang YJ, Ma CS, Han YL, Chen SL, Li H, Zhang RY, Fu GS, Yuan ZY, Jiang H, Huo Y, Li W, Zhang YJ, Leon MB; TARGET I Investigators. Gao RL, et al. Among authors: xu b. EuroIntervention. 2013 May 20;9(1):75-83. doi: 10.4244/EIJV9I1A12. EuroIntervention. 2013. PMID: 23685298 Free article. Clinical Trial.

8

Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.

Han Y, Zhu G, Han L, Hou F, Huang W, Liu H, Gan J, Jiang T, Li X, Wang W, Ding S, Jia S, Shen W, Wang D, Sun L, Qiu J, Wang X, Li Y, Deng J, Li J, Xu K, Xu B, Mehran R, Huo Y. Han Y, et al. Among authors: xu k, xu b. J Am Coll Cardiol. 2014 Jan 7-14;63(1):62-70. doi: 10.1016/j.jacc.2013.09.017. Epub 2013 Sep 26. J Am Coll Cardiol. 2014. PMID: 24076297 Free article. Clinical Trial.

9

Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: 12-month results from the TARGET II trial.

Xu B, Zhao Y, Yang Y, Zhang R, Li H, Ma C, Chen S, Wang J, Huo Y, Leon MB, Gao R. Xu B, et al. Chin Med J (Engl). 2014;127(6):1027-32. Chin Med J (Engl). 2014. PMID: 24622429 Clinical Trial.

10

Validation and comparison of the long-term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention.

Xu B, Généreux P, Yang Y, Leon MB, Xu L, Qiao S, Wu Y, Yan H, Chen J, Zhao Y, Zhao Y, Palmerini T, Stone GW, Gao R. Xu B, et al. Among authors: xu l. JACC Cardiovasc Interv. 2014 Oct;7(10):1128-37. doi: 10.1016/j.jcin.2014.05.018. Epub 2014 Sep 17. JACC Cardiovasc Interv. 2014. PMID: 25240551 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16,678 results

Search Page